NCT00434083View on ClinicalTrials.gov

To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

January 31, 2005

Conditions
Migraine Headaches
Interventions
DRUG

sumatriptan

DRUG

naproxen sodium

Trial Locations (2)

27517

Pozen, Inc., Chapel Hill

37203

Nashville Neuroscience Group, PC, Nashville

Sponsors

Lead Sponsor

POZEN
All Listed Sponsors
lead

POZEN

INDUSTRY

NCT00434083 - To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches | Biotech Hunter | Biotech Hunter